SA

Shubham Arora

Director Director DIN 02759515
DIN 02759515 First appointment Nov 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2013
Shareholding value Locked Premium profile

About Shubham Arora

Data last updated:

Shubham Arora has 12 years in corporate governance. Formerly with 1 company, such as Ambrosia Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02759515
Primary Designation Director
First Appointment 20 Nov 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ambrosia Drugs Private Limited U51397UR2004PTC028742
Director20 Nov 20132004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ambrosia Drugs Private Limited
Premium access

Shareholding and investment profile for Shubham Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Arora

Shubham Arora has 12 years in corporate governance. Formerly with 1 company, such as Ambrosia Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Shubham Arora is associated with 0 companies as a director.

Shubham Arora has expertise in General Business.

Shubham Arora has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available